These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical expression of survivin in oral epithelial dysplasia and different grades of oral squamous cell carcinoma. Ghritlahare H; Einstein A; Singaraju S; Patel S; Gulati N; Mishra SD J Oral Maxillofac Pathol; 2022; 26(4):451-457. PubMed ID: 37082058 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of osteopontin expression in oral squamous cell carcinoma. Jeyasivanesan DL; Mohamed SP; Pandiar D; Basheer S Indian J Dent Res; 2019; 30(4):539-543. PubMed ID: 31745049 [TBL] [Abstract][Full Text] [Related]
4. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632 [TBL] [Abstract][Full Text] [Related]
5. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma]. Liu YM; Huang JH; Feng DY; Guo XC Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of cyclooxygenase-2 in oral squamous cell carcinoma. Thomas N; Krishnapillai R; Bindhu PR; Thomas P Indian J Dent Res; 2019; 30(1):102-106. PubMed ID: 30900666 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
9. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma. Liu S; Shi L; Yang X; Ye D; Wang T; Dong C; Guo W; Liao Y; Song H; Xu D; Hu J; Zhang Z; Deng J Cell Cycle; 2017 May; 16(9):894-902. PubMed ID: 28384094 [TBL] [Abstract][Full Text] [Related]
10. Expression of epithelial glycoprotein (EGP40) in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC). Srichinthu KK; Kumar GS; Prasad H; Rajmohan M; Anuthama K; Yoithapprabhunath TR Indian J Dent Res; 2020; 31(5):738-742. PubMed ID: 33433512 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study. Kotrashetti VS; Nayak R; Bhat K; Hosmani J; Somannavar P Biotech Histochem; 2013 Aug; 88(6):311-22. PubMed ID: 23651260 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of endothelin protein in oral squamous cell carcinoma. Alaizari NA; Abdelbary SN; Amin NR Indian J Pathol Microbiol; 2013; 56(2):151-4. PubMed ID: 24056654 [TBL] [Abstract][Full Text] [Related]
13. Analysis of immunohistochemical expression of k19 in oral epithelial dysplasia and oral squamous cell carcinoma using color deconvolution-image analysis method. Safadi RA; Musleh AS; Al-Khateeb TH; Hamasha AA Head Neck Pathol; 2010 Dec; 4(4):282-9. PubMed ID: 20882374 [TBL] [Abstract][Full Text] [Related]
15. MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study. Abidullah M; Nahar P; Ahmed SA; Kothari H; Vakeel S J Int Soc Prev Community Dent; 2023; 13(2):124-132. PubMed ID: 37223448 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation. Angadi PV; Krishnapillai R Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma. Zaid KW Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218 [TBL] [Abstract][Full Text] [Related]
18. The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma. Simionescu C; Mărgăritescu C; Surpăţeanu M; Mogoantă L; Zăvoi R; Ciurea R; Surlin P; Stepan A Rom J Morphol Embryol; 2008; 49(2):189-93. PubMed ID: 18516325 [TBL] [Abstract][Full Text] [Related]
19. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865 [TBL] [Abstract][Full Text] [Related]
20. Nuclear Survivin as a Prognostic Factor in Squamous-Cell Carcinoma of the Oral Cavity. Santarelli A; Mascitti M; Rubini C; Bambini F; Giannatempo G; Lo Russo L; Sartini D; Emanuelli M; Procaccini M; Lo Muzio L Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):566-570. PubMed ID: 27389554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]